Ex vivo modulation of chemical-induced mutagenesis by subcellular liver fractions of rats treated with rooibos (Aspalathus linearis) tea, honeybush (Cyclopia intermedia) tea, as well as green and black (Camellia sinensis) teas

Mutation Research - Genetic Toxicology and Environmental Mutagenesis

Volumn 558, Issue 1-2, 2004, Pages 145-154

  Marnewick, J L ^a   Batenburg, W ^a   Swart, P ^b   Joubert, E ^c   Swanevelder, S ^a   Gelderblom, W C A ^a  

^a SOUTH AFRICAN MEDICAL RESEARCH COUNCIL   (South Africa)

^b STELLENBOSCH UNIVERSITY   (South Africa)

^c ARC INFRUITEC NIETVOORBIJ   (South Africa)

Author keywords

2 Acetylaminofluorene; Aflatoxin B1; Ex vivo protection; Honeybush; Mutagenesis; Rooibos

Indexed keywords

AFLATOXIN B1; ASPALATHUS LINEARIS EXTRACT; BLACK TEA EXTRACT; CYCLOPIA INTERMEDIA EXTRACT; GREEN TEA EXTRACT; N (2 FLUORENYL)ACETAMIDE; PLANT EXTRACT; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; ASPALATHUS LINEARIS; BACTERIAL STRAIN; CELL FRACTIONATION; CELLULAR DISTRIBUTION; CHEMICAL MUTAGENESIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYCLOPIA INTERMEDIA; CYTOSOLIC FRACTION; DRUG EFFECT; LIVER CELL; LIVER MICROSOME; MALE; MUTAGEN TESTING; NONHUMAN; PRIORITY JOURNAL; RAT; SALMONELLA; TEA;

ASPALATHUS LINEARIS; CAMELLIA; CAMELLIA SINENSIS; CYCLOPIA; SALMONELLA;

EID: 1242317085     PISSN: 13835718     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrgentox.2003.12.003     Document Type: Article

References (53)

1. Guengerich F.P. Metabolism of chemical carcinogens. Carcinogenesis. 21:2000;345-351.
2. Chen H.Y., Yen G.C. Possible mechanisms of antimutagens by various teas as judged by their effects on mutagenesis by 2-amino-3-methylimidazo[4,5-f] quinoline and benzo[a]pyrene. Mutat. Res. 393:1997;115-122.
3. 1 genotoxicity in rats treated by organosulfur compounds from garlic. Carcinogenesis. 23:2002;1335-1341.
4. Waters M.D., Stack H.F., Jackson M.A., Brockman H.E., De Flora S. Activity profiles of antimutagens: in vitro and in vivo data. Mutat. Res. 350:1996;109-129.
5. Yang C.S., Brady J.F., Hong J.Y. Dietary effects on cytochromes P450, xenobiotic metabolisms and toxicity. FASEB J. 6:1992;737-744A.
6. 1 metabolism. Carcinogenesis. 18:1997;1729-1738.
7. Kano S., Ikeda M., Tokudome S., Kuratsune M. A case-control study of gastric cancer and diet in northern Kyushu, Japan. Jpn. J. Cancer Res. 70:1988;1067-1074.
8. Hertog M.G.L., Hollman P.C.H., Katan M.B., Kromhout D. Intake of potentially anticarcinogenic flavonoids and their determinants in adults in The Netherlands. Nutr. Cancer. 20:1993;21-29.
9. Chen J. The effects of Chinese tea on the occurrence of oesophageal tumours induced by N-nitromethylbenzylamine in rats. Prev. Med. 21:1992;385-391.
10. Gao Y.T., McLaughlin J.K., Blot W.J., Ji B.T., Di Q., Fraumeni J.F. Reduced risk of oesophageal cancer associated with green tea consumption. J. Natl. Cancer Inst. 86:1994;855-858.
11. Yen G.C., Chen H.Y. Comparison of antimutagenic effect of various tea extracts (green, oolong, pouchong and black tea). J. Food Prot. 57:1994;54-58.
12. Weisburger J.H., Hara Y., Dolan L., Luo F.Q., Pittman B., Zang E. Tea polyphenols as inhibitors of major classes of carcinogens. Mutat. Res. 371:1996;57-63.
13. Bu-Abbas A., Clifford M.N., Walker R., Ioannides C. Marked antimutagenic potential of aqueous green tea extracts: mechanisms of action. Mutagenesis. 9:1994;325-331.
14. C.P. Thunberg, Travels in Europe, Africa and Asia, Made Between the Years 1770 and 1779, in: W. Richardson, J. Egertan (Eds.), vol. 4, third ed., Routledge, London, 1795.
15. Blommaert K.L.J., Steenkamp J. Tannien en moontlike kafeieninhoud van rooibos tea, Aspalathus (Subgen. Nortiera) linearis (Brum. Fil) R. Dahlg. Agroplantae. 10:1978;93.
16. H.G. Greenish, Cape tea, 3rd Ser., Pharmaceut. J. Trans. 550 (1881) 549-551.
17. S.E. Terblanche, Report on Honeybush Tea, Department of Biochemistry, University of Port Elizabeth, Port Elizabeth, South Africa, 1982.
18. Standley L., Winterton P., Marnewick J.L., Gelderblom W.C.A., Joubert E., Britz T.J. Influence of processing stages on antimutagenic and antioxidant potentials of rooibos tea. J. Agric. Food Chem. 49:2001;114-117.
19. M.E. Hubbe, E. Joubert, In vitro superoxide anion radical scavenging activity of honeybush tea (Cyclopia intermedia), in: I.T. Johnson, G.R. Fenwick (Eds.), Dietary anticarcinogens and antimutagens-chemical and biological aspects, The Royal Society of Chemistry, Cambridge, UK, 2000, pp. 242-244.
20. Von Gadow A., Joubert E., Hansmann C.F. Comparison of the antioxidant activity of rooibos tea (Aspalathus linearis) with green, oolong and black tea. J. Agric. Food Chem. 60:1997;73-77.
21. Inanami O., Asanuma T., Inukai N., Jin T., Shimokawa S., Kasai N., Nakano M., Sato F., Kuwabara M. The suppression of age-related accumulation of lipid peroxides in rat brain by administration of Rooibos tea (Aspalathus linearis). Neurosci. Lett. 196:1995;85-88.
22. Y. Shindo, K. Kator, Effect of rooibos tea on some dermatological diseases, in: Proceedings of the International Symposium on Tea Sciences, The Organising Committee of ISTS, Shizuoka, Japan, 1991, pp. 385-389.
23. Sasaki Y.-K., Yamada H., Shimoi K., Kator K., Kinea N. The clastogen-suppressing effects of green tea, Po-lei tea and rooibos tea in CHO cells and mice. Mutat. Res. 286:1993;221-232.
24. Marnewick J.L., Gelderblom W.C.A., Joubert E. An investigation on the antimutagenic properties of South African herbal teas. Mutat. Res. 471:2000;157-166.
25. Rabe C., Steenkamp J.A., Joubert E., Burger J.F.W., Ferreira D. Phenolic metabolites from rooibos tea (Aspalathus linearis). Phytochemistry. 35:1994;1559-1565.
26. Bramati L., Minogio M., Gardana C., Simonetti P., Mauri P., Pietta P. Quantitative characterization of flavonoid compounds in rooibos tea (Aspalathus linearis) by LC-UV/DAD. J. Agric. Food Chem. 50:2002;5513-5519.
27. Ferreira D., Kamara B.L., Brandt E.V., Joubert E. Phenolic compounds from Cyclopia intermedia (honeybush tea). J. Agric. Food Chem. 46:1998;3406-3410.
28. Kamara B.I., Brandt E.V., Ferreira D., Joubert E. Polyphenols from honeybush tea (Cyclopia intermedia). J. Agric. Food Chem. 51:2003;3874-3879.
29. Hollman P.C.H., Tijburg L.B.M., Yang C.S. Bioavailability of flavonoids from tea. Crit. Rev. Food Sci. Nutr. 37:1997;719-738.
30. Hara Y., Luo S.-J., Wickremasinghe R.L., Yamanishi T. Chemical composition of tea. Food Rev. Int. 11:1995;435-456.
31. Yang C.S., Wang Z.-Y. Tea and cancer. J. Natl. Cancer Inst. 85:1993;1038-1049.
32. Joubert E. Effect of controlled conditions during deep bed processing and drying on rooibos tea (Aspalathus linearis). J. Food Process. Preserv. 22:1998;405-417.
33. Du Toit J., Joubert E. Optimisation of the fermentation parameters of honeybush tea (Cyclopia). J. Food Quality. 22:1999;241-256.
34. J.L. Marnewick, E. Joubert, P. Swart, F. Van der Westhuizen, W.C.A. Gelderblom, Modulation of hepatic drug metabolising enzymes and oxidative status by green and black (Camellia sinensis), rooibos (Aspalathus linearis) and honeybush (Cyclopia intermedia) teas in rats, J. Agric. Food Chem. 51 (2003) 8113-8119.
35. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:1976;248-254.
36. Maron D.M., Ames B. Revised methods for the Salmonella mutagenicity test. Mutat. Res. 113:1983;173-215.
37. Omura T., Sato R. The carbon monoxide binding pigment of liver microsomes, solubilization, purification and properties. J. Biol. Chem. 239:1964;2379-2385.
38. Bu-Abbas A., Nunez X., Clifford M.N., Walker R., Ioannides C. A comparison of the antimutagenic potential of green, black and decaffeinated teas: contribution of flavonols to the antimutagenic effect. Mutagenesis. 11:1996;597-603.
39. Catterall F., Copeland E., Clifford M.N., Ioannides C. Contribution of theafulvins to the antimutagenicity of black tea: their mechanism of action. Mutagenesis. 13:1998;631-636.
40. Wang Z.Y., Khan W.A., Bickers D.R., Mukhtar H. Protection against polycyclic aromatic hydrocarbon-induced skin tumour initiation in mice by green tea polyphenols. Carcinogenesis. 10:1989;411-415.
41. Brown M.D. Green tea (Camellia sinensis) extract and its possible role in the prevention of cancer. Alternative Med. Rev. 4:1999;360-370.
42. Weisburger J.H. Tea and health: the underlying mechanisms. Proc. Soc. Exp. Biol. Med. 220:1999;271-275.
43. Guengerich F.P. Roles of cytochrome P450 enzymes in chemical carcinogenesis and cancer chemotherapy. Cancer Res. 48:1988;2946-2954.
44. Kensler T.W. Chemoprevention by inducers of carcinogen detoxification enzymes. Environ. Health Perspect. 105:1997;965-970.
45. Wang Z.Y., Das M., Bickers D.R., Mukhtar H. Interaction of epicatechins derived from green tea with rat hepatic cytochrome P450. Drug Metab. Dispos. Biol. Fate Chem. 16:1988;98-103.
46. Ayrton A.D., Neville S., Ioannides C. Cytosolic activation of 2-aminoanthracene: implications in its use as a diagnostic mutagen in the AMES test. Mutat. Res. 268:1992;1-8.
47. Leist M., Ayrton A.D., Ioannides C. A cytosolic oxygenase activity involved in the bioactivation of 2-aminofluorene. Toxicology. 71:1992;7-20.
48. Heflich R.H., Neft R.E. Genetic toxicity of 2-acetylaminofluorene, 2-aminofluorene and some of their metabolites and model metabolites. Mutat. Res. 318:1994;73-114.
49. Hodek P., Trefil P., Stiborova M. Flavonoids-potent and versatile biologically active compounds interacting with cytochromes P450. Chem. Biol. Interact. 139:2002;1-21.
50. Siess M-H., Le Bon A-M., Canivenc-Lavier M-C., Suschetet M. Mechanisms involved in the chemoprevention of flavonoids. BioFactors. 12:2000;193-199.
51. Sohn O.S., Surace A., Fiala E.S., Richie J.P., Colosimo S., Zang E., Weisburger J.H. Effects of green and black tea on hepatic xenobiotic metabolising systems in male F344 rat. Xenobiotica. 24:1994;119-127.
52. Lin J.-K., Liang Y.-C. Cancer chemoprevention by tea polyphenols. Proc. Natl. Sci. Counc. Repub. China B. 24:2000;1-13.
53. Maliakal P.P., Coville P.F., Wanwimolruk S. Tea consumption modulates hepatic drug metabolising enzymes in Wistar rats. J. Pharm. Pharmcol. 53:2000;569-577.